About Us
About Senores Group
Milestone
Manufacturing Capabilities
Formulations
API
Products
Formulations
API
Partnership
R&D Pipeline
Formulations
API
Career
Contact
Media
Media Coverage
MAY 2022
Dr. Reddy's and Senores Pharmaceuticals, Inc. launches Ketorolac Tromethamine Tablets (Source: Bloomberg)
MAR 2022
Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launches Butalbital, Acetaminophen and Caffeine Capsules (Source: Yahoo Finance)
JAN 2022
Senores Pharmaceuticals, Inc. launches Mexiletine Hydrochloride Capsules (Source: Market Insider)
OCT 2021
Cintex Services, LLC and Senores Pharmaceuticals, Inc. launches Chlorzoxazone Tablets (Source: BioSpace)
NOV 2020
Jubilant Pharma Ltd. and Aavis Pharmaceuticals launches Hydroxychloroquine Sulfate Tablets (Source: Seeking Alpha)
Press Release
MAY 2022
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. launches Ketorolac Tromethamine Tablets in the U.S. market
MAR 2022
Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launches Butalbital, Acetaminophen and Caffeine Capsules in the U.S. market
JAN 2022
Senores Pharmaceuticals, Inc. launches Mexiletine Hydrochloride Capsules with one of the top 5 generic pharmaceutical companies in the U.S. market
OCT 2021
Cintex Services, LLC and Senores Pharmaceuticals, Inc. launches Chlorzoxazone Tablets in the U.S. market
NOV 2020
Jubilant Pharma Ltd. and Aavis Pharmaceuticals Inc. launches Hydroxychloroquine Sulfate Tablets in the U.S. market
